Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

FDA Classifies Worldwide Voluntary Correction Notice on TRUFILL® n-BCA Liquid Embolic System as Class I Recall

Posted Jan 22 2014 11:41am
Codman Neuro announced today that the U.S. Food and Drug Administration (FDA) has classified the recently initiated medical device correction notice related to the TRUFILL® n-BCA Liquid Embolic System as a Class I recall.
Post a comment
Write a comment:

Related Searches